REFLAB ApS: Financial statements 2015
CVR: 15322586
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
REFLAB ApS (CVR 15322586) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 2,968,148 and a net result of DKK -381,585 compared with DKK 1,080,544 the year before. That is a decrease of 36% compared with the year before. Equity in the 2015 report amounted to DKK 3,479,886. The solvency ratio was 81.1%.
- Gross Profit
- DKK 2,968,148
- Profit/Loss
- DKK -381,585
- Equity
- DKK 3,479,886
- Total Assets
- DKK 4,291,134
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 3 mio. | -382 t. | 3.5 mio. | - |
| 2014 | - | 4.6 mio. | 1.1 mio. | 3.9 mio. | - |
| 2013 | - | 3.7 mio. | 98 t. | 2.8 mio. | - |
| 2012 | - | 2.5 mio. | -65 t. | 2.7 mio. | - |
Official annual report
How creditworthy is REFLAB ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
REFLAB ApS has published its annual report for 2014. Gross profit came to DKK 4,638,963, and the net result was DKK 1,080,544.
About REFLAB ApS
REFLAB ApS is a Danish company of the type Anpartsselskab based in Hvidovre, founded in 1991. The company is registered under the industry Traditionelle, komplementære og alternative behandlingsformer. The company was previously named REFERENCELABORATORIET ApS. The management consists of Gert Pynt Andersen and Katrine Baumann Markussen. The company is owned by R-Biopharm AG. The company has 7 employees (2018). In 2025, the company reported a gross profit of DKK 4,582,184 and a net result of DKK -1,792,430 compared with DKK 652,577 the year before. Equity in the 2025 report amounted to DKK -635,048.